QA: Cellectar Biosciences Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2022_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.005531342739369355, 'aggregate_val': 37201809, 'exp_sum': 36997165, 'exp_to_value': {'AssetsCurrent': 36571460, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 344491, 'remainder_Assets': 81214}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001279704')"}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc.

  xvar xval
0 AssetsCurrent 36,571,460
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 344,491
3 remainder_Assets 285,858
4 LiabilitiesCurrent 3,990,363
5 LiabilitiesNoncurrent 166,292
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,544,811
9 ResearchAndDevelopmentExpense 17,586,469
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 8,918
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 37,201,809
1 Liabilities 4,156,655
2 Expenses 24,131,280
3 Revenues 0
4 StockholdersEquity 33,045,154
5 NetIncome -24,122,362
6 ComprehensiveNetIncome -24,122,362
7 BaseVar 32,749,331
8 EconomicCapitalRatio 1.58

Edgar->Model Mapping

Feature Distribution

Change over Time